The results from KEGG enrichment showed that the IL-17 pathway, mainly including NF-κB, AP-1 and various related inflammatory factors, might be involved in the treatment of the five flavonoids against liver cirrhosis. This evidence concerns the gene JUN and cirrhosis of liver.